← Leaderboards
Elias T Zambidis
Johns Hopkins University
$6,212,497
Attributed
$6,232,997
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $700.6K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,232,997 · 5
By mechanism
R01$5,526,447 · 3
K08$665,550 · 1
R03$41,000 · 1
Top collaborators
- Alan D Friedman1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Peter A Campochiaro$21,020,539
- Thomas Vincent Johnson$1,430,567
- Stanley A Vinores$2,405,911
- Iulian Ioan Iordachita$5,636,644
- Quan Dong Nguyen$2,032,478
Others in their field
Top investigators on “Progenitor”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$60,084,971
- Linda M Brzustowicz · Rutgers The St Univ Of Nj New Brunswick$50,700,892
- Michael L. Terrin · Clinical Trials And Surveys Corporation$33,854,173
- David Heimbrook · Leidos Biomedical Research, Inc.$31,285,017
- Edward E Morrisey · University Of Pennsylvania$31,076,582
- Irving Lerner Weissman · Stanford University$30,527,953
Research focus
ProgenitorStem CellsEmbryoFutureGenerationsFibroblastsEpigenetic ProcessCell TherapyAdultAutologousLegal PatentIschemiaInduced Pluripotent Stem CellBlood CapillariesMcam GenePericytesDiabetes MellitusAnimal ModelNatural RegenerationNeural RetinaEngraftmentDiabetic RetinopathyBlood VesselsCxcr4 Gene
Grant awards (20)
Embryonic vascular stem-progenitors for treatment of ischemic retinopathies$442,564
R01 · FY2024 · EY · contact PI
Embryonic vascular stem-progenitors for treatment of ischemic retinopathies$529,181
R01 · FY2023 · EY · contact PI
Embryonic vascular stem-progenitors for treatment of ischemic retinopathies$534,804
R01 · FY2022 · EY · contact PI
Embryonic vascular stem-progenitors for treatment of ischemic retinopathies$527,300
R01 · FY2021 · EY · contact PI
Functional Vascular Progenitors from Naive Human iPSC$336,150
R01 · FY2019 · HD · contact PI
Pluripotent Stem Cell Vascular Therapies for Ischemic Retinopathies$364,500
R01 · FY2018 · EY · contact PI
Functional Vascular Progenitors from Naive Human iPSC$336,150
R01 · FY2018 · HD · contact PI
Pluripotent Stem Cell Vascular Therapies for Ischemic Retinopathies$364,500
R01 · FY2017 · EY · contact PI
Functional Vascular Progenitors from Naive Human iPSC$336,150
R01 · FY2017 · HD · contact PI
Pluripotent Stem Cell Vascular Therapies for Ischemic Retinopathies$364,500
R01 · FY2016 · EY · contact PI
Functional Vascular Progenitors from Naive Human iPSC$332,788
R01 · FY2016 · HD · contact PI
Pluripotent Stem Cell Vascular Therapies for Ischemic Retinopathies$357,210
R01 · FY2015 · EY · contact PI
Functional Vascular Progenitors from Naive Human iPSC$336,150
R01 · FY2015 · HD · contact PI
Pluripotent Stem Cell Vascular Therapies for Ischemic Retinopathies$364,500
R01 · FY2014 · EY · contact PI
Transcriptional and Epigenetic Regulation of HSC Generated from iPS and ESC$41,000
R03 · FY2009 · HL
Origin of HSC from Embryonic Stem Cells$133,110
K08 · FY2008 · HL · contact PI
Origin of HSC from Embryonic Stem Cells$133,110
K08 · FY2007 · HL · contact PI
Origin of HSC from Embryonic Stem Cells$133,110
K08 · FY2006 · HL · contact PI
Origin of HSC from Embryonic Stem Cells$133,110
K08 · FY2005 · HL
Origin of HSC from Embryonic Stem Cells$133,110
K08 · FY2004 · HL